In patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), semaglutide reduced the risk of clinically important kidney...
Events
In patients with type 2 diabetes and kidney disease, Ozempic (semaglutide) reduced kidney disease progression, major adverse cardiovascular events (MACE)...